HIV-1 displays extensive genetic diversity. Group M includes 9 subtypes and \>45 circulating recombinant forms (CRFs) ([@R1]). In western and central Africa, where the highest levels of HIV-1 genetic heterogeneity are observed, most subtypes cocirculate along with CRFs and unique recombinant forms (URFs). This diversity may complicate diagnosis and treatment of HIV infection and represents a challenge for vaccine design. In North America, the HIV-1 epidemic is dominated by subtype B; non-B subtypes are infrequently reported ([@R2]*,*[@R3]). Nonetheless, recent studies have shown a growing prevalence of non-B variants ([@R4]*,*[@R5]). In 2005, Akouamba et al. reported high levels of HIV-1 genetic diversity among participants in the Centre Maternel et Infantile sur le SIDA (CMIS) antenatal cohort of Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montreal, Canada ([@R6]). Of these patients, 44 of 103 were infected with non-B subtypes, including 4 variants that failed to group within known subtypes in phylogenetic analyses ([@R6]). We performed near full-length genomic sequencing to characterize these 4 unassigned variants.

The Study
=========

All 4 patients were newcomers to Canada from sub-Saharan Africa who received prenatal care at CMIS during 1999--2003 ([@R6]). Patient TV721 emigrated from the Democratic Republic of Congo, TV749 from Congo, and TV725 and TV919 from Rwanda. HIV-1 viral loads at study entry, measured by the Versant HIV-1 RNA 3.0 assay (bDNA) (Bayer, Pittsburgh, PA, USA), with a limit of detection of 50 RNA copies/mL plasma, were 164--23,369 RNA copies/mL plasma. CD4+ T cell counts ranged from198 cells/mm^3^ to 816 cells/mm^3^ ([Table](#T1){ref-type="table"}). Standardized clinical follow-up, including antiretroviral prophylaxis and treatment, was provided to all women and their children. This study was conducted according to the guidelines of the Ethics Review Board of CHU Sainte-Justine.

###### Virologic and immunologic parameters in patients participating in antenatal cohort, Canada\*

  Patient   Age, y   CD4 count, cells/mm^3^   Viral load, RNA copies/mL   Antiretroviral treatment
  --------- -------- ------------------------ --------------------------- --------------------------
  TV721     33.2     210                      164                         AZT-3TC-NVP
  TV725     30.1     816                      739                         None
  TV749     34.1     198                      23,369                      AZT-3TC-NFV
  TV919     34.0     420                      1,910                       AZT-3TC-NFV

\*AZT, zidovudine; 3TC, lamivudine; NVP, nevirapine; NFV, nelfinavir.

Viral RNA was extracted from serum and amplified by using custom-designed primers and the QIAGEN OneStep reverse transcription--PCR (QIAGEN, Mississauga, ON, Canada) (sequences available on request). For each isolate, 14--20 amplicons spanning the complete genome were generated and subcloned into pCR 2.1 TOPO (Invitrogen, Carlsbad, CA, USA). For each amplicon, we sequenced 3--10 independent clones (Beckman-Coulter, Palo Alto, CA, USA). Chromatograms were edited with Chromas version 1.45 (Technelysium, Southport, Queensland, Australia). Overlapping segments were aligned by using ClustalX version 1.81 ([@R7]) and assembled manually. Consensus sequences were generated by selecting the most frequent nucleotide at each position. We performed bootscan analyses according to the neighbor-joining method and Kimura 2-parameter distances using a 300-nt window and 10-nt increments (Simplot 3.5.1) ([@R8]). These parameters allow accurate localization of recombination breakpoints in HIV-1 recombinants ([@R9]). We computed phylogenetic reconstructions based on the neighbor-joining method and Kimura 2-parameter distances by using MEGA4 ([@R10]) to confirm recombinant structures. Bootstrap values \>80% were considered significant.

Complete HIV-1 genomic sequences were obtained from patients TV721 (9,794 nt) and TV749 (9,791 nt). Genomic coverage of 79.3% and 91.6% was achieved for patients TV725 (7,763 nt) and TV919 (8,905 nt), respectively. On the basis of HXB2 numbering ([@R1]), missing regions were located between positions 545--1411 and between 6946--7930 for patient TV725, and between positions 7138 and 7834 for patient TV919. Screening of HIV-1 genomic sequences from patient TV721 with the HIVdb Genotypic Resistance Interpretation Algorithm (<http://hivdb6.stanford.edu/asi/deployed/HIVdb.html>) showed minor resistance mutations to protease inhibitors (L10I) and integrase inhibitors (I203M). Mutations associated with minor resistance to protease inhibitors (L10I) and non-nucleoside reverse transcription inhibitors (E138A) were detected in sequences from patient TV919, and a mutation conferring high-level resistance to delavirdine (P236L) was detected in patient TV725. In contrast, sequences from patient TV749 did not show mutations associated with resistance to antiretroviral agents ([@R11]). Previous subtyping, based on phylogenetic analyses of *pol* gene sequences, showed that sequences from patients TV721 and TV749 grouped together (100% bootstrap) but only loosely with clade J references (61% bootstrap); sequences from patients TV725 and TV919 grouped outside all major clades ([@R6]). Bootscan analysis showed complex recombinant structures for all 4 full-length or near full-length genomes ([Figure](#F1){ref-type="fig"}). Sequences derived from patients TV721 and TV749 comprised regions from subtype J but were also similar to subtypes A1 and A2 ([Figure](#F1){ref-type="fig"}). Examination of the homology, position, and sharing of recombination breakpoints suggests that HIV-1 isolates infecting patients TV721 and TV749 may be closely related recombinants, perhaps resulting from common-source transmission or representing a novel CRF or URF. Reciprocal bootscan analyses that included subtypes A1, A2, and J supported this assessment (data not shown). However, a review of the medical files and case histories of patients TV721 and TV749 did not confirm epidemiologic relatedness. Although multiple CRFs and URFs contain segments related to subtypes A and J, sequences from patients TV721 and TV749 are 2 of only 3 full-length HIV-1 genomes reported that exclusively comprise sequences related to subtypes A and J ([@R12]). The genomic structure of 98BW21.17 resembles that of sequences from patients TV721 and TV749 in terms of chimerism, but the location of recombination breakpoints is distinct (data not shown).

![Genetic organization and recombination breakpoints in HIV-1 genomic sequences isolated from patients TV721 (A), TV725 (B), TV749 (C), and TV919 (D). Nucleotide sequences were submitted to GenBank (accession nos. HM215249--HM215252). Similarity plots were produced with Simplot version 3.5.1 (<http://sray.med.som.jhmi.edu/SCRoftware/simplot>) by using windows of 500 nt and increments of 50 nt to guide the choice of reference sequences used for bootscanning ([@R8]). Bootscan analyses were then performed according to the neighbor-joining method and Kimura 2-parameter distances. The size of the sliding window was set at 300 nt with 10-nt increments ([@R9]). Reference sequences used were subtype A1: A1.AU.03 (DQ676872), A1.KE.94 (AF004885), A1.RW.92 (AB253421); subtype A2: A2.CD.97 (AF286238), A2.CY.94 (AF286237); subtype D: D.CD.83.ELI (K03454), D.CM.01 (AY371157), D.TZ.01 (AY253311); subtype G: G.BE.96 (AF084936), G.KE.93 (AF061641), G.NG.92 (U88826); subtype J: J.CD.97 (EF614151), J.SE.93 (AF082394), J.SE.94 (AF082395); and CRF11_cpx: 11_cpx.CM.95 (AF492624). Phylogenetic reconstructions based on the neighbor-joining method and the Kimura 2-parameter distance model were computed by MEGA4 ([@R10]) and used to confirm the structures of the recombinants. Bootstrap values \>80% (500 replicates) were considered significant. Vertical dashed lines indicate the position of recombination breakpoints. Numbering of residues is based on the sequence of HIV-1 HXB2 (GenBank accession no. K03455).](10-0629-F){#F1}

Sequences from patients TV725 and TV919 grouped outside all major clades in phylogenetic analyses of *pol* gene sequences ([@R6]). Bootscan analysis of the HIV-1 strain infecting patient TV725 clearly demonstrated that this variant comprised segments most closely related to subtypes A1 and D ([Figure](#F1){ref-type="fig"}). Sequences from patient TV725 display a recombination pattern resembling that of CRF35_AD, the only other A1/D intersubtype recombinant described, which was recently identified in Kabul, Afghanistan ([@R13]). CRF35_AD and TV725 share A1 backbones, and recombination points bordering clade D segments are comparatively close (positions 2166--2444 for CRF35_AD and 2133--2360 for the isolate infecting patient TV725; positions 2901--3538 for CFR35_AD and 2897--3659 for TV725). However, they differ with respect to a clade D--related segment at positions 9044--9489 in TV725 ([Figure](#F1){ref-type="fig"}). Finally, analysis of TV919 sequences showed complex A1/G/J mosaicism and similarities with CRF11_cpx, in terms of clade composition and localization of recombination breakpoints ([@R14]). Including the CRF11_cpx reference sequence 95CM1816 in bootscan analysis highlighted the similarities between sequences from patient TV919 and CRF11_cpx ([Figure](#F1){ref-type="fig"}), which extends from positions 3227 to 7137 and includes segments corresponding to subtypes A1, G, and J. The most distinctive difference between the isolate infecting patient TV919 and CRF11_cpx started at position 7835; the former sequentially clustered with subtypes A1, J, and G, CRF11_cpx closely associated with subtypes J, A1, and E. Thus, the isolate infecting patient TV919 represents a novel A/G/J/CRF11_cpx recombinant. The HIV-1 isolates that infected patients TV721, TV725, TV749, and TV919 had more recombination breakpoints and unclassified regions than most CRFs and URFs, highlighting their unique recombination profiles and structural complexity.

Conclusions
===========

We identified novel HIV-1 recombinants infecting pregnant women in Montreal. None of the 4 patients transmitted HIV-1 to their children. No evidence was found that these particular variants currently circulate within the Canadian population. Thus, the HIV-1 isolates infecting patients TV721, TV725, TV749, and TV919 must be construed as URFs. In North America, only 1 URF, also isolated in Montreal, was characterized by near full-length genomic sequencing ([@R5]). Given the ongoing movement of the population from areas where the disease is endemic into regions in which subtype B predominates, reports of novel HIV-1 recombinants are likely to increase and include complex mosaic genomes. Biological properties of recombinant subtypes might differ from those of other clades, particularly in terms of HIV disease progression ([@R15]) and drug resistance. In terms of public health, antenatal cohorts represent unique sentinel sites to monitor the emergence of novel HIV-1 variants, including complex mosaic recombinants, in countries where their prevalence is low.
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